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Abstract 
 
PPARγ is a nuclear receptor protein that has a central role in promoting adipocyte growth and 
differentiation, as well as regulating serum glucose and triglyceride levels. Under normal 
physiological conditions, PPARγ is a target of several post-translational modifications 
(PTMs) that modulate its transcriptional activity. One particular PTM, phosphorylation of 
Ser245 in the ligand-binding domain (LBD) by cyclin-dependent kinase 5 (CDK5) leads to 
down-regulation of specific genes that promote insulin sensitivity, increasing the risk of type 
2 diabetes and cardiovascular diseases. Earlier studies have shown that some PPARγ ligands 
can lead to the inhibition of Ser245 phosphorylation by CDK5 and restore the basal gene 
expression of PPARγ and increase insulin sensitivity. The mechanism of this inhibition from 
the molecular point of view is not completely understood. While it has been previously 
suggested that ligand binding leads to the establishment of a series of interactions that 
effectively prevent the formation of PPARγ-CDK5 interaction surface, to date, there are no 
experimental structures to support this hypothesis. To that end, we used molecular dynamics 
simulations to investigate the effects of different ligands on the structure and dynamics of this 
region of the protein. Using both classical and accelerated dynamics approaches, we studied 
PPARγ-ligand complexes containing ligands with three different activation profiles, the full 
agonist rosiglitazone, partial agonist MRL24 and a non-agonist decanoic acid, that resembles 
an endogenous PPARγ ligand. Our observations show that the binding of a ligand to the 
active site of PPARγ correlates well with the global stability of PPARγ LBD, especially in 
the case of rosiglitazone, effectively restricting the dynamics and conformational space of 
residues, encompassing the PPARγ-CDK5 interaction surface. Further research is required to 
discern the difference between ligands of distinct inhibitory and agonistic profiles on the 
dynamical and conformational properties of PPARγ. 
 
Keywords: nuclear receptor, PPARγ, CDK5, phosphorylation, molecular dynamics 
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1. Introduction 
 
1.1. Nuclear receptors 
 
 The peroxisome proliferator-activated receptor gamma (PPARγ) is part of the nuclear 
hormone receptor superfamily (NRs), which is a large family of DNA-binding proteins that 
are responsible for regulation of numerous processes at the cellular level, such as cell 
differentiation, cell proliferation, apoptosis and maintenance of cellular homeostasis [1]. 
Since they are implicated in various physiological and pathological processes, the NR 
superfamily is one of the largest and pharmaceutically important receptor superfamilies. In 
total, there are 48 NRs that are encoded in the human genome. 
 
1.2. General structure of nuclear receptors 
 
 The general structure of typical NR (Figure 1) is composed of six domains [2]. The 
most conserved domain is the DNA-binding domain (DBD) or the C domain, which is on 
average 66 amino acids long and contains two zinc finger motifs that are responsible for 
recognizing specific DNA half-site sequences, called response elements, and the formation of 
dimerization interface in receptors that form dimers. The second most conserved domain is 
the ligand-binding domain (LBD) or the E domain, which is often the largest domain. The E 
domain contains the ligand-dependent activation function or activation function 2 (AF-2). In 
between the DBD and the LBD lies the hinge region or the D domain, which displays high 
variability in amino acid length and sequence among NRs. The two remaining domains, 
which are also highly variable in terms of size and sequence, are the N-terminal domain or 
the A/B domain which harbors the ligand-independent transcriptional activation function 
(AF-1), and, in many but not all NRs, the C-terminal domain or the F domain, whose 
function is not completely understood. 
 
 
Figure 1: Schematic of the general sequence of NR domains. Source: Adapted from 
Wikipedia, the free encyclopedia. 
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1.3. Transcriptional regulation of nuclear receptors with ligand binding 
and post-translational modifications 
 
 
Figure 2: The mechanism of ligand dependent transcriptional activation os NRs. Source: W. 
Zita, University of Strasbourg/IGBMC, modified from Wikipedia, the free encyclopedia.  
 
 The transcriptional activity of NRs is for the most part regulated by the two activation 
functions common to all NRs.  The AF-1, located in the N-terminal domain, modulates the 
formation of an interaction surface with various transcriptional coregulatory proteins [2], but 
there is very little structural data to support this because of the unstructured nature of the A/B 
domain. 
 The other activation function, AF-2, is also responsible for modulating the interaction 
of NRs with different coregulatory proteins. Several mutation and deletion studies [3] have 
shown that the core part of AF-2 is a short segment at the C-terminus of the LBD, which is 
also known as the activation helix. Essentially, a local conformational change and 
stabilization of the activation helix associated with the binding of a ligand is responsible for 
triggering the entire transcriptional machinery, beginning with the dissociation of corepressor 
and binding of a primary coactivator. This enables recruitment of a variety of additional 
coactivators that catalyze the local unwinding of chromatin and end with the formation of the 
transcriptional preinitiation complex (PIC) and the mediator complex, which carry on with 
the transcription of target genes (Figure 2). In addition to the two activation functions, all 
domains of NRs are subject to a vast variety of different post-translational modifications, 
such as phosphorylation, acetylation and SUMOylation, modulating the cell-specificity and 
transcriptional activity of NRs [2]. 
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1.4. Nuclear receptor PPARγ, structure of its ligand-binding domain and 
mechanisms of transcriptional modulation at the site of LBD 
 
 PPAR receptor family is comprised of three receptors (PPARα, β/δ and γ), all of 
which are important in regulation of lipid and glucose metabolism across different tissues [4]. 
PPARγ in particular is responsible for regulating adipocyte differentiation and energy storage 
by fatty acid uptake and lipogenesis. PPARγ exists in two isoforms, PPARγ1 and PPARγ2, 
differing structurally in length of the N-terminal domain and functionally, in tissue 
specificity. In the nucleus, PPARγ forms an obligate heterodimer with the NR retinoid X 
receptor alpha (RXR), which itself binds to the DNA response element with the DR-1 direct 
repeat architecture [5]. The transcription of target genes by heterodimeric NRs can be 




Figure 3: Structure of the LBD of PPARγ, PDB ID: 2PRG (created using Open-Source 
PyMOL ™ [6]. 
 
The tertiary structure of the LBD of PPARγ (Figure 3) can be described as a three-layered 
alpha-helical sandwich with one antiparallel beta sheet [7]. Structurally, the most important 
part of this domain with respect to transactivation is the H12 helix, or the activation helix, 
which is crucial for ligand-dependent activation of transcription machinery. In the unliganded 
receptor, the H12 helix is not firmly anchored to the LBD core, with helices H3, H4 and H11 
forming the corepressor interaction surface. The binding of an agonist to the LBD shifts the 
orientation of the AF-2 helix towards the H3 and H4 helices, allowing for the molecular 
recognition of a number of coactivators through the specific LXXLL coactivator recognition 
motif, where L is for the Leucine amino acid and where X is any amino acid [5, 7].  
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1.5. The link between phosphorylation of PPARγ by CDK5 and 
pathophysiology of obesity-related diseases 
 
 In obese invidivuals, the enlarged and inflamed adipose tissue secretes adipokines 
carrying signals for the influx of macrophages into the adipose tissue [8]. Macrophages 
produce pro-inflammatory molecules TNF-α, IL1β and resistin, which downregulate the 
expression of genes for insulin-sensitizing adipokines adiponectin and adipsin. Loss of 
insulin sensitivity results in increased insulin secretion from the pancreatic β-cells, which 
potentially leads to the development of Type 2 diabetes (T2D), and other obesity-related 
diseases [9]. 
 PPARγ is a master regulator of genes that control lipogenesis and insulin signaling. 
Choi et al. [9] have shown that in a state of obesity, one of the factors contributing to 
increased insulin resistance is the phosphorylation of PPARγ on serine 245 (S273 in PPARγ 
isoform 2), mediated by cyclin-dependent kinase 5 (CDK5), which is activated by binding to 
its regulatory protein partner p35. In inflamed adipose tissue, the elevated levels of pro-
inflammatory cytokines and fatty acids catalyze the cleavage of p35 to a more active and 
stable p25 segment. The binding of CDK5 to p25 results in translocation of CDK5 to the 
nucleus and, subsequently, an increased rate of S245 phosphorylation, the effect of which is 
dysregulation of target genes encoding for adiponectin and adipsin. For this reason, inhibition 
of S245 phosphorylation by ligand binding has been proposed as a possible approach to 
revert the expression of adiponectin and adipsin to basal levels and restore insulin sensitivity 
in T2D patients. 
 
1.6. Molecular mechanism of the ligand-dependent propensity of PPARγ 
for phosphorylation by CDK5 
 
The thiazolidinediones or TZDs, such as rosiglitazone, have been the most notable drugs used 
in the treatment of insulin resistance [10] (Figure 4 A). These compounds are full agonists of 
PPARγ. However, due to numerous deleterious effects arising from their potent agonistic 
profiles that instigate overexpression of PPARγ target gemes, the use of TZDs has since been 
discouraged. All ligands that exhibit partial agonism relative to TZDs have been termed 
''selective PPARγ modulators''  or SPPARMs. SPPARMs were shown to be equally efficient, 
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or in some cases, such as MRL24 (Figure 4 B), even better than drugs from the TZD class at 




Figure 4: A) Rosiglitazone, a representative of the TZD class, B) MRL24, 
a selective PPARγ modulator. Created using MarvinSketch 19.20.0 
 
The detailed molecular mechanism underlying the inhibition of phosphorylation of PPARγ by 
CDK5 is still not completely understood despite numerous attempts at elucidating differential 
structural changes associated with binding of different ligands [12, 13, 14]. In addition, the 
lack of distinct structural changes between the different PPARγ/agonist complexes suggests 
that structural dynamics might also contribute to the differential consequences of ligand 
binding. In order to design novel and potent antidiabetic drugs, a comprehensive analysis of 
the mechanism of protein-ligand interactions resulting in the inhibitory effect is required.  
2. Objectives of the internship 
 
 The main objective of this internship project is to study the effects of different ligands 
on the structural dynamics and structural conformation of the LBD of PPARγ. The secondary 
objective is to correlate the effects of ligands to their experimentally measured inhibitory 
activity against phosphorylation by CDK5. 
 The approach taken in this project is motivated by a set of hypotheses, formulated 
from previous molecular modelling and HDX experimental observations of other groups 
(Mottin et al. [12], Ribeiro Filho et al. [13], and Montanari et al. [14]) In particular: 
- that the primary site of PPARγ interaction with CDK5 is at the H2-H2’ loop and that distal 
regions, in particular, the β-sheet region, and the H2-H3’ loop are important for stabilization 
of PPARγ-CDK5 interaction  
- that residues I341 and M348 play a crucial role in the inhibition of phosphorylation by the 
formation of hydrophobic interactions, stabilizing these regions  
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3. Materials and Methods 
 
3.1. Molecular Dynamics Simulations 
 
3.1.1. MD simulation principles 
 
 Molecular dynamics (MD) simulation is an important tool for the study of structural 
and dynamical properties of molecular and atomic systems [15]. In essence, MD simulations 
involve setting up initial conditions (i.e. positions, velocities) of each particle in the system 
and calculating the subsequent trajectories of particles using Newton's equations of motion. 
In this research project, we used the the CHARMM [16] and NAMD [17] programs, 
developed specifically for MD simulations of biomolecular systems. 
 Of fundamental importance  for MD simulations is the potential energy function, or 
force field (Equation 1).  The force field is the functional form of the potential energy surface 
as a function of all atomic coordinates of the system U(R). It consists of several energy 
terms, grouped under bonded and non-bonded terms. 
 
𝑈(𝑹) =  ∑ 𝑘𝑏 ∗ (𝑏 − 𝑏0)
2
𝑏𝑜𝑛𝑑𝑠
+ ∑ 𝑘𝑏 ∗ (𝜃 − 𝜃0)
2
𝑎𝑛𝑔𝑙𝑒𝑠
+ ∑ 𝑘𝑈𝐵 ∗ (𝑆 − 𝑆0)
2
𝑈𝑟𝑒𝑦−𝐵𝑟𝑎𝑑𝑙𝑒𝑦
+ ∑ 𝑘𝛷(1 + cos(𝑛𝛷 − 𝛿))
𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠
+ ∑ 𝑘𝜔(𝜔 − 𝜔0)
2
𝑖𝑚𝑝𝑟𝑜𝑝𝑒𝑟𝑠




















 The first five terms are the bonded energy terms, which describe the interactions 
between covalently bound atoms. The non-bonded energy terms consist of the 6-12 Lennard-
Jones potential term that describes the van der Waals attraction and repulsion, and the 
electrostatic term, which describes Coulombic interaction between two point charges. The 
CMAP term is is used to improve conformational properties of protein backbones. 
 The potential energy function can be used to calculate the derivatives, which can be 
used to determine forces on each atom to propagate the evolution of system with time. 
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3.1.2. Building the models for MD simulations 
 
 The first step in the preparation of biomolecular models for MD simulations is 
obtaining the structures of biological macromolecules as described by atomic coordinates. 
For the purpose of this project, we chose five x-ray crystallographic structures of the PPARγ 
LBD. Two structures were of the apo protein (PDB ID: 1PRG [18]),  (PDB ID: 3B3K [19]) 
and three structures of complexes of the PPARγ LBD with rosiglitazone (PDB ID: 2PRG 
[18]), MRL24 (PDB ID: 2Q5P [20]) and decanoic acid (PDB ID: 3U9Q [21]). From here on, 
we will reference the different structures by their PDBIDs. To better conform to the 
experimental conditions used by our collaborators, all simulations were of the LBD monomer 
and ligand, no co-activator peptide was included. To make the data present in the PDB files 
more homogeneous, the PDB files were pre-processed in the following ways: 
 
1PRG: Chain B and the surrounding water molecules were removed, leaving chain A. 
3B3K: Chain A and the surrounding water molecules were removed, leaving chain B. 
2PRG: Chains B and C and the surrounding water molecules were removed, leaving chain A  
2Q5P: Chain B and surrounding water molecules were removed, leaving chain A.  
3U9Q: Chains B,C and surrounding water molecules were removed, leaving chain A.  
 
 In some cases, the choice of chain was dictated by the number of missing coordinates 
of flexible regions, such as loops and terminal ends. Before the simulations could be run, the 
missing coordinates had to be determined by a homology modeling type of approach. Given 
that the sequences of the missing chain segments and of the complete template, 2PRG, were 
identical, we applied a simple approach, where coordinates from the template structure are 
copied to the target after structure superposition with the PyMOL program.  This was done 
for amino acids K261 – S274 of 2Q5P and for K263-S274 of structure 3U9Q. This approach 
can be considered as a simple application of comparative structural modeling [22].  
 Besides missing residue coordinates, hydrogen atoms, which are inherently absent 
from x-ray crystallographic structures, were placed in the structure using the HBUILD 
module [23] of the CHARMM program during the construction of the Protein Structure File 
(PSF). In addition, the protonation states of histidine were estimated with propka web 
application [24] and visual inspection of structures with the PyMOL program. All other 
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amino acids were kept in their standard protonation states. The choices of His protonation 
states are displayed in the Annex, under section 3. 
 The last preprocessing step before model building with CHARMM was resolving the 
discrepancies between pdb and CHARMM atom notation, of which there are several. For this 
purpose, the in-house Leto program was used [25], which transforms the original pdb files 
into CHARMM-compatible pdb files, segments them into constituent pdb files for protein 
structure, ligand and water molecules, and writes out the protein structure file (PSF), an 
important file format for CHARMM calculations. The PSF contains information on structure 
connectivity, atom types and atomic charges for all the molecules in the system. 
 After the generation of the PSF file, we proceeded with the energy minimization of 
initial structure. For each protein structure, we first removed all crystallographic water 
molecules beyond an 8Å distance from the protein, keeping only nearby waters. Afterwards, 
we performed 700 steps of steepest descent optimization method. During the energy 
minimization, the protein backbone and side chain atoms were subject to harmonic force 
constraints, to prevent the minimization from moving the protein too far away from the native 
tertiary structure. For the evaluation of long-range van der Waals interactions, a switch cutoff 
was used, with the inner cutoff and outer cutoff radii equal to 8.0 Å and 12.0Å, respectively. 
For electrostatic interactions, a distance-dependent dielectric constant was used, with epsilon 
equal to 4.0 and the shift cutoff with cutoff radius equal to 12.0Å. 
 The minimization was followed by the solvation of the stucture in explicit water, 
using the TIP3P model for water molecules, with the dielectric constant equal to one. Each 
minimized protein structure was placed inside a cubic box, with 100 Å side length, with 
periodic boundary conditions imposed on the system. To ensure the convergence of the PME 
summation,a small fraction of explicit water molecules beyond the protein surface was 
replaced by sodium and chloride ions so that the total charge remained neutral. 
 
3.1.3. Running the MD simulations 
 
 The energy-minimized and solvated psf and pdb structure files were transferred from 
the local computers to the University of Strasbourg mesocentre where the remaining MD 
simulation steps including the trajectory production were carried out using the NAMD 
program. The final steps before production included additional energy minimization, heating 
and equillibriation of the system to the target temperature of 293.15 K. The PME method [26] 
was used at all steps of the NAMD calculations for treating electrostatic interaction, while the 
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switch cutoff was used for van der Waals interactions with inner and outer radius equal to 
8.0Å and 12.0Å, respectively. For the equillibriation and production steps, the Verlet 
integrator was used to calculate the coordinates and velocities with the integration timestep 
set to 2 fs. The potential energy function (Equation 1) was parametrized with the 
CHARMM36 all-atom force field [27]. The equilibration consisted of 100K steps while the 
trajectory production was realized by consecutive segments of 1M steps. The final production 
time amounted to 50 production segments for each system, which is equal to 100 ns of 
classical MD simulations per system. For all simulation steps the NVE ensemble was used.   
For each system, 5 independent simulations were run in order to increase the space of 
conformations sampled. 
 
3.2. Accelerated Molecular Dynamics Simulations 
 
3.2.1. aMD principles 
 
 One of the more severe limitations of classical molecular dynamics of biomolecular 
systems is inability of attaining reasonable time scale of simulations when it comes to 
sampling rare dynamical events, such as conformational transitions. A number of 
workarounds have been developed in the field of molecular dynamics, to treat different 
simulation problems, together known as enhanced sampling methods. The enhanced 
sampling method used in this project, called accelerated molecular dynamics (aMD) [28], is 
universally applicable in simulations of biomolecular systems and it does not assume any 
prior information on metastable states of protein structures. In our internship project, we used 
a modification of the original aMD, called the dual-boost aMD method (aMDdual) [29]. For 
a more details of the aMD method, see section 1 in the Annex. 
 
3.2.2.  Calculating the aMD parameters and running the aMD simulations 
 
 The first classical MD simulation runs of structures with rosiglitazone, MRL24, 
decanoic acid, and an apo PPARγ structure (1PRG) were prepared for 100 ns of aMD 
simulations. The potential energy values of first 10 ns of production step for each classical 
simulation were used to estimate the parameters of the aMDdual method. Their respective 
values are displayed in the table in the Annex, under section 2. For all four structures, we ran 
a set of three independent 100 ns aMD simulations in the NPT emsemble with target 
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temperature and pressure of 293.15 K and 1.01325 bar, respectively. The treatment of non-
bonded interactions remained the same as in the classical simulations. 
 
3.2.3.  Analysis of aMD trajectories with stochastic proximity embedding 
 
 In order to obtain a deeper insight into the time evolution of different PPARγ 
structures, we used dimensionality reduction on trajectories from aMD simulations, 
featurized in terms of pseudo C-alpha dihedral angles. 
 In this project, we used Unrolr [30], a python package for analysis and visualization 
of MD simulation trajectories based on the pivot-based Stochastic Proximity Embedding 
(pSPE) dimensionality reduction [31]. The package was developed during the thesis research 
of Dr. Jerome Eberhardt in the host lab and is available on github at 
https://github.com/jeeberhardt/unrolr. The details of the method are described in the Annex, 
under section 5. 
 The trajectory files from three independent runs of aMD simulations were 
concatenated and featurized by unrolr.feature_extraction.Dihedral object, which extracts the 
pseudo C-alpha dihedral angles from every frame and stores them into hdf5 file. The distance 
between two conformations in the set was measured by the dihedral distance metric [32] 
(Equation 2), which is invariant to translation and rotation of two structures, 













where a and b are two conformations and M is the number of dihedral angles. The optimal 
neighborhood radius pSPE parameter was determined using the 
unrolr.sampling.neighborhood_radius_sampler module (for further details, see Annex, 
section 5). Afterwards, the module unrolr.Unrolr was used to compute the dihedral distances 
and obtain the 2D pSPE embeddings of trajectories. For each structure, the entire set of 600K 
frames was used for pSPE projection. To speed up the computation, we used OpenCL 
implementation of Unrolr, which enables the user to run the program on heterogenous 
platforms. In the same manner, we also computed a global embedding of all trajectories of 
the four PPARγ structures, consisting of 2.4M frames. We used 10K pSPE optimization 
cycles in all computations.  
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4. Results and Discussion 
 
4.1. Classical molecular dynamics 
 
4.1.1. RMSD time series 
 
The Root-Mean-Square Deviation (RMSD) of structures sampled along the simulation with 
respect to the starting structure provides the first insight into structural stability and global 
conformational changes over the course of the simulation. Given two structures, the RMSD is 
calculated as  







where u and v are vectors of atomic coordinates of two structures and N is the number of 
atoms over which the average is being calculated. We evaluated the RMSD of all backbone 
atoms vs time for the 100 ns classical MD simulations of PPARγ LBD structures in complex 
with rosiglitazone (2PRG),  MRL24 (2Q5P), decanoic acid (3U9Q) and the two apo 
structures (1PRG) and (3B3K). The initial structure for the respective simulation was used as 
the reference structure. 
 
 
Figure 5: The RMSD time series for the different classical simulations of each complex.  
The RMSD was calculated for the protein backbone after superposition on the reference 
structure to remove global translation and rotation.  The different lines correspond to 
independent simulations of the respective system. 
 
  17 
 The results (Figure 5) show that all structures stabilize over the course of the 
simulation. The low RMSD values of the PPARγ complex with rosiglitazone indicate that it 
is the most stable structure. On the contrary, one of the apo structures (3B3K) and the PPARγ 
complex with decanoic acid display a higher variability of RMSD time series over different 
repetitions of simulations, indicating that those structures are more flexible. 
 
4.1.2. RMSD per residue 
 
 The RMSD per residue measures the distance between a chosen group of atoms in 
two aligned structures, where one of the structures is chosen as a reference structure. It can 
tell us which parts of the protein chain undergo greater degrees of conformational change. 
The RMSD per residue is defined as the Mean-Square Deviations, averaged over a subset of 
atoms Nj, for example, the backbone atoms of a particular residue.  The calculation is 
repeated for each residue of the protein. 








 We calculated the RMSD per residue of each PPARγ structure, using the same 
reference structure as in the RMSD timeseries calculations. Figure 6 displays the average 
values of RMSD per residue for all structures. In all structures, the large values for helices 
H2, H2' as well as the H2-H2' and H2'-H3 loops indicate that these are by far the regions of 
PPARγ that undergo the largest conformational changes. The high RMSD values at H12 for 
the apo (3B3K) structure indicate that the H12 helix undergoes significant conformational 
change when in its unliganded conformation. Apart from theses observations, other parts of 
the sequence show relatively small conformational changes and the behavior is roughly 
similar for all five complexes. So, this measure can not be readily used to differentiate 
between ligands that inhibit phosphorylation and those that do not. We also note that at the 
position of S245, indicated by a yellow marker on the Figure 6, there is no discernable 
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Figure 6: Plot of RMSD per residue for the classical simulations of each complex. Lines 
represent mean RMSD values of backbone C, Calpha and N atoms over 5 independent 100 ns 
simulations, each simulation averaged over 2000 evenly spaced frames. 
 
4.1.3. Analysis of distribution of side chain dihedral angles of I341, M348, I249 and 
L255 
 
 Based on the backbone RMSD profiles alone, we could not draw any conclusions 
regarding the correlation between ligand's inhibitory profiles and their effects on protein 
structure and dynamics. For this reason, we decided to investigate the side chains of several 
amino acids in the ligand binding pocket (LBP) of PPARγ. A recent publication of Ribeiro 
Filho et al. [13] suggested that the binding of a phosphorylation inhibitor into the LBP 
induces a conformational change of I341 side chain, establishing a series of hydrophobic 
interactions between I341 and the side chains of residues M348, I249 and L255, located at 
the β-sheet region. We used the MDAnalysis Python library [33, 34] to calculate the 
distribution of side chain dihedral angles 1 and 2 for the putative residues. For each 
structure, the 1 and 2 distribution over the entire set of five 100ns simulations was extracted 
using the MDAnalysis.analysis.dihedrals.Janin() object. In the case of I341, the difference in 
distribution between structures with phosphorylation inhibitors (rosiglitazone and MRL24) 
and other structures is significant (Figure 7). For 1, the trimodal distribution changes to a 
nearly unimodal distribution centered around 60 degrees with structures containing 
rosiglitazone and MRL24. For 2, the peak at 300 degrees disappears. For M348, I249 and 
L255, the differences in 1 and 2 distributions among PPAR structures were either not as 
significant (I249 and L255) or could not be attributed to the inhibitory ligand binding effect 
(M348) (see Annex section 4 for the 1  and 2 distribution plots of other amino acids). 
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Figure 7: Histograms of the X1 (blue) an X2 (orange)  I341 side chain dihedral angles for 5 
independent runs of classical simulations of each complex. The range of X1 and X2 values is 
divided into 100 bins. The probability distributions are delineated by gaussian kde curves. 
 
4.2. Accelerated molecular dynamics 
 
 Here, we ran 3 independent runs of 100 ns aMD simulations in the aMDdual mode, of 
PPARγ complexes with rosiglitazone (2PRG), MRL24 (2Q5P), decanoic acid (3U9Q) and an 
apo PPARγ structure (1PRG). The energy-minimized and desolvated structure from the final 
preprocessing step was chosen as reference for each complex. 
 
4.2.1.  RMSD time series 
 
 We evaluated RMSD vs time for the aMD simulations in the same manner as for the 
classical simulations. The RMSD timeseries, displayed in the Figure 8, show that the 
deviation of structures from initial conditions are more pronounced compared to the classical 
MD simulations (Figure 5), as one would expect. In all cases, except for PPARγ – MRL24 
complex where the RMSD values of all 3 independent runs plateau at approximately 4 Å, the 
positive slope of the curves indicate that the structures are still evolving from the initial 
coordinates. 
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Figure 8: The RMSD time series for the different aMD simulations of each complex.  RMSD 
was calculated for the protein backbone after superposition on the reference structure. The 
different lines correspond to independent simulations of the respective system. 
 
4.2.2. RMSD by residue 
 
 From the values in the RMSD by residue plot (Figure 9), we can observe that on 
average, the PPAR complexes with Rosiglitazone and MRL24 are somewhat more stable 
relative to the PPAR complex with decanoic acid and the apo protein, especially in part of 
the sequence from H8 onwards. On the contrary, the RMSD values at the N-terminal end of 
LBD show a less clear distinction between liganded and unliganded structures. In the case of 
PPAR - MRL24, the prominent peak at the H2-H2' loop, hints that this region undergoes a 
more significant conformational change than the other complexes during the simulations. 
 
 
Figure 9: Plot of RMSD per residue for the classical simulations of each complex. Lines 
represent mean RMSD values, averaged over 2000 evenly spaced frames from 100 ns 
simulations. 
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4.2.3. Analysis of aMD trajectories with Stochastic Proximity Embedding 
 
 The embeddings obtained from the Unrolr calculations on the aMD trajectories reveal 
the parts of conformational space of PPAR LBD explored during aMD simulations, which 
contains several highly-populated and close lying metastable states. Figure 10 shows the 
embeddings of 3 concatenated 100 ns trajectories for PPARγ – rosiglitazone complex. The 
blue-colored areas correspond to clusters with a high number of binned conformations, which 
are similar according to the dihedral distance and hence, are projected closely to one another 
by pSPE. They can be directly linked to highly-populated metastable states of the proteins. 
On the other hand, red-colored areas have a low number of binned conformations and 
correspond to sparsely populated transition states or unfolded conformations. 
 Using the Visualize package developed in the host lab by J. Eberhardt (Github: 
https://github.com/jeeberhardt/visualize), we extracted structures from different clusters of 
the pSPE embeddings. In all simulations, the highly-populated clusters correspond to either 
conformations in the initial state, or conformations where the helices H2, H2', H12 and the 
beta sheet b1 are partially or fully unfolded, confirming that these are the most flexible 
regions of the PPAR LBD (see also Annex section 6 for the embeddings of other structures). 
 
 
Figure 10: Unrolr pSPE embedding for PPARγ – Rosiglitazone. The conformations are 
binned with a bin size of 0.005 in both dimensions. Six densely-populated clusters with 25 
aligned structures from each cluster are shown in the insets. Position of helix H1 in the 
aligned structures is labeled for clearance. 
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 From the dihedral angle hdf5 files extracted from independent runs of each complex, 
we used Unrolr to compute the global embedding of all aMD simulations, using 24000 
frames for neighborhood radius optimization and all 2400000 for the final projection (Figure 
11). 
 
Figure 11: The global embedding of all aMD simulations. A, Scatter plot with a color 
map, showcasing the conformational space of structures with different ligands. B. 
Density map of the same embedding, using a bin size of 0.005 in both dimensions. 
 
 
 Of interest is the observation, that the apo and decanoic acid complexes explore a 
more extensive conformational space than the simulations of rosiglitazone complex, 
correlating well with the fact that rosiglitazone is a strong agonist that stabilizes the LBD of 
PPARγ.  The simulations of PPARγ with MRL24 show that, in this case, the LBD also 
samples more extensively the conformational space than rosiglitazone, but still shows more 
overlap with the space sampled by the rosiglitazone complex than that observed for the 
others.  This could contribute to understanding why MRL24 is a less strong agonist. 
Additional simulation runs would be required, as from the global embedding (Figure 11), it is 
evident that different simulations diverge and never return to explore the same region of 
conformational space. It would also be interesting to set up and run simulations with other 
ligands, in an attempt to associate the effect of binding of different ligands on the 
conformational space of PPARγ. 
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5. Conclusion 
 
 In this work, classical MD and accelerated molecular dynamics (aMD) simulation 
techniques were used to probe the structural conformational dynamics of the ligand-binding 
domain (LBD) of the nuclear receptor PPARγ, in apo form and in complex with ligands.  
 The study by classical MD encompassed evaluation of RMSD time series, the 
analysis RMSD by residue, and the analysis of flexibility of side chain dihedral angles of 
residues, involved in beta sheet stabilization of different structures. The RMSD timeseries, 
and the values of RMSD by residues, show that overall, the most stable structure is the 
complex of PPARγ with rosiglitazone. For other structures, we observed negligible 
correlation between ligands with different profiles and the supposed stability of the regions 
involved in PPARγ - CDK5 interaction. For this reason, we decided to explore the effect of 
ligand binding on several putative residues I341, M348, I249 and L255, involved in β-sheet 
stabilization and hypothesized to be implicated in phosphorylation inhibition. We observed 
that both rosiglitazone and MRL24 restrict the conformational freedom of I341 side chain. 
For other residues, the association between ligand binding and side chain conformational 
change could not be clearly established. A further investigation in this direction, using more 
diverse ligands is required. 
 The study by aMD simulations involved RMSD time series and RMSD by residue 
analysis for three independent runs of structures of PPARγ in complex with rosiglitazone 
(2PRG), MRL24 (2Q5P), decanoic acid (3U9Q) and an apo PPARγ structure (1PRG). Again, 
the PPARγ complex with rosiglitazone turned out to be the most stable. To visualize the 
extent of conformational space exploration of different structures, we used Unolr program 
that computes 2D embeddings of featurized trajectories with pSPE method. The pSPE 
embeddings reveal that all structues explored a large number metastable states, differing 
mainly in the conformations of the H2 and H2' helix, and the H2-H2' and H2'-H3 loop. The 
global embedding shows that all trajectories diverge in different directions after leaving the 
initial state. The apo structure and the PPARγ - decanoic acid complex are more spread out 
than the PPARγ – MRL24 and PPARγ – rosiglitzone complexes. Both observations suggest 
that the binding of a ligand to the LBD has a significant effect on the conformational space of 
PPARγ. For future perspectives, to discern between PPARγ ligands of different agonistic and 
phosphorylation inhibition profiles, an evaluation of the effect on PPARγ conformational and 
dynamical properties with a more diverse set of ligands would be required. 
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Abbreviation list 
 
PPAR: Peroxisome-proliferator activated receptor. 
PTM: Post-translational modification. 
NR: Nuclear receptor. 
DBD: DNA-binding domain. 
LBD: Ligand binding domain. 
AF: Activation function. 
RXRα: Retinoid x receptor alpha. 
DR: Direct repeat. 
TNF: Tumor necrosis factor. 
IL1β: Interleukin 1 beta. 
T2D: Type 2 Diabetes. 
CDK5: Cyclin-dependent kinase 5. 
TZD: Tiazolidinedions. 
SPPARM: Selective PPAR modulator. 
HDX: Hydrogen-deuterium exchange. 
MD: Molecular dynamics. 
CHARMM: Chemistry at Harvard molecular mechanics. 
NAMD: Nanoscale Molecular Dynamics 
PDB: Protein Data Bank 
PSF: Protein Structure File. 
PME: Particle-Mesh Ewald. 
aMD: Accelerated Molecular Dynamics. 
pSPE: Pivot-based Stochastic Proximity Embedding. 
RMSD: Root-mean-square deviation. 
LBP: Ligand-binding pocket. 
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Annex 
 
1. Desription of the accelerated molecular dynamics (aMD) method 
The key idea behind aMD enhanced sampling method is that the potential energy surface is 
modified by raising the energy of all conformations where the potential energy falls below a 
certain value. In this manner, the energy basins are “filled in”, thus facilitating the transition 
between different metastable conformations. This effect is achieved by adding a continuous 
non-negative, threshold-dependent function ∆V(r), also called the boost potential, to the 
system's true potential energy function V(r). The functional form of the modified potential 
energy landscape V'(r) is written as: 
 
𝑉′(𝑟) = 𝑉(𝑟) +  ∆𝑉(𝑟) ∗ 𝐻(𝐸 − 𝑉(𝑟)) (A1) 
 
where E is the boost energy, a predefined value and H(E-V(r)) is the Heaviside step function, 
which is equal to 1 if E > V(r) and 0 otherwise. The choice of ∆V(r) employed in the original 




𝛼 + (𝐸 − 𝑉(𝑟))
 (A2) 
 
where α controls the shape of the modified potential energy surface below the boost energy 
E. When α is equal to 0, potential energy below E is flattened out, whereas when α is set to a 
high value, the true potential energy is recovered. The choice of E and α depends on the 
problem at hand but is usually determined by running a classical MD simulation on the 
system beforehand and calculating the average potential energy on the unmodified potential 
energy surface. 
 A popular mode of aMD is the dual boost aMD (aMDdual), where the boost potential 
∆V(r) is split into the dihedral contribution, consisting of boosted dihedral energy terms and 
the (total-dihedral) contribution, containing the boosts for the remaining terms [29]. In this 
way, it is possible to finely-tune the extent of conformational sampling. 
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2. aMD boost potential parameters 
 
 PPARγ ligand 
Boost potential 
parameters 
rosiglitazone MRL24 decanoic acid apo structure 
accelMDE 3663 3688 3647 3855 
accelMDalpha 216 216 216 256 
accelMDTE -324314 -324124 -324376 -167458 
accenMDTalpha 20933 20939 20947 10860 
Supplementary Table 1: Boost potential parameters for the aMDdual mode in NAMD. 
accelMDE, accelMDalpha – threshold energy E and acceleration factor α for the dihedral 
potential, accelMDTE, accelMDTalpha – threshold energy E and acceleraton factor α for the 
(total – dihedral) potential. 
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3. Protonation states of histidine residues 
 


















217 HSE HSE HSE HSE HSE 
266 HSE HSD HSD HSD HSD 
323 HSE HSD HSD HSD HSD 
425 HSP HSP HSP HSE HSE 
449 HSE HSE HSE HSE HSE 
466 HSE HSD HSD HSE HSE 
Supplementary table 2: Protonation states of histidine residues in different PPARγ 
structures. HSD – proton on Nδ, HSE – proton on Nε, HSP – proton on both Nδ and Nε of 
HIS. 
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Supplementary figure 1: Histograms of the X1 (blue) an X2 (orange)  M348 (A), I249 
(B) and L255 (C) side chain dihedral angles for 5 independent runs of classical 
simulations of each complex. The range of dihedral angle values is divided into 100 
bins. The corresponding probability distributions are delineated by gaussian kernel 
density estimate curves. 
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5. Unrolr and the pSPE method 
 
6.1. pSPE algorithm basics 
 
 The pivot-based Stochastic Proximity Embedding (pSPE) method used by Unrolr is a 
nonlinear dimensionality reduction method, an unsupervised machine learning method that 
aims to discover the geodesic distance-preserving low dimensional representation of the input 
dataset. The geodesic distance is defined as the length of the shortest path between two given 
points on a manifold. Since pSPE does not make any assumption on the functional form of 
the manifold in the input dimension, the true geodesic distances cannot be readily calculated 
by integration and are instead approximated by simpler distance metrics, such as Euclidean 
distance. The core idea of pSPE relies on the fact that the Euclidean distance always 
represents the lower bound to the true geodesic distance. For this reason, geodesic distance 
between neighboring points can be reasonably approximated by the Euclidean distance 
metric.  
 
The pseudocode for pSPE method is as follows: 
 
1. Define λ, rc, m, C and ε 
2. Randomly distribute N configurations on a m-dimensional hyperplane 
3. For 0 to C do: 
3.1. Randomly select a point xi from N configurations as a pivot 
3.2. For j≠i do: 
3.2.1. dij = euclidean_distance(xi,xj) 
3.2.2. Dij = dihedral_distance(xi,xj) 
3.2.3. If (Dij < rc) OR (Dij > rc AND dij < Dij) then: 
 





3.2.4. END If 
3.3. END For 
3.4. Decrease λ by a small positive value dλ 
4. END For 
5. Return 
 
 where ε is a small number to avoid division by zero if two points are very close in 
space, Dij is the dihedral distance and dij is the euclidean distance between conformations i 
and j in the input and low-dimensional space, respectively, C is the number of optimization 
cycles and λ is the learning rate that decreases linearly as the learning progresses. The 
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coordinate update rule of  pSPE method in the inner loop ensures that the distance in the low-
dimensional space is never lower than the true geodesic distance in the input space. In this 
way, pSPE prioritizes accurate projections of local data points distances and only 
approximate projections for non-local data points. The parameter which controls the degree 
of locality in the projected space and therefore the space of embedding is the neighborhood 
radius, rc. If the value of rc is too low, the embbedding will appear as a group of disconnected 
clusters. Conversely, if rc is too high or in the limit rc → ∞, the method can no longer infer 
nonlinear relationships beetween the input features. Therefore, the optimal choice of rc is 
crucial, as it allows to envision the true topology of explored regions on the potential energy 
surface. 
 
5.2. Determining the optimal neighborhood radius in the pSPE method 
 
 The neighborhood radius (𝑟𝑐) is the most important parameter of pSPE method, 
determining the quality of low-dimensional projection. In the original implementation of 
pSPE method, the choice of the neighborhood radius is determined by minimizing the 
Kruskal’s stress objective function (Equation A3). The stress function measures the deviation 
of distances between objects in the projected space 𝛿𝑖𝑗 from the distances between 









𝑤ℎ𝑒𝑟𝑒 𝑓(𝛿𝑖𝑗 , 𝛥𝑖𝑗) =  {
(𝛿𝑖𝑗−𝛥𝑖𝑗)
2    𝑖𝑓    𝛿𝑖𝑗 ≤ 𝑟𝑐 𝑜𝑟 𝛿𝑖𝑗 < 𝛥𝑖𝑗 





 The key property of the stress function is that it only takes into account input 
distances, closer than the neighborhood radius. In this sense, it measures, how accurate are 
projections on the local level. The stress of zero would correspond to the ideal projection 
given the neighborhood radius. Unrolr also keeps track of the correlation between original 
and projected distances, given by the equation 
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where 𝛥 and 𝛿 are vectors of all distances in the input space  and all distances in the low-
dimensional space, 𝛿̅ , ?̅? their means and 𝜎𝛿, 𝜎𝛥 their standard deviations, respectively. The 
correlation function (Equation A4) is equal to 0 if the distances are totally uncorrelated and 1 
if the distances are exactly correlated. It is used to avoid the group of disconnected clusters 
case at low values of neighborhood radius. Increasing the neighborhood radius increases both 
stress and correlation. Therefore the ideal value of neighborhood radius is when the 
difference between both functions is the largest, which roughly corresponds to the situation 
when correlation reaches a plateau and stress starts rapidly increasing.  
 The data from each of the four sets of concatenated trajectories encompassed 600000 
frames with 267 dihedral angles. To make the search for optimal 𝑟𝑐  more computationally 
feasible, we chose a heuristic optimization approach, where for each set, only 1% of all 
frames (6000 frames, every 3 ns) was used in Unrolr. The stress and correlation functions 
were varied in the range 0 ≤ 𝑟𝑐  ≤ 1 with increments of 0.01. For each 𝑟𝑐 value, 5 individual 
runs of 5000 iterations were carried out.  
 The plots of Stress and Correlation versus 𝑟𝑐 of different sets of simulations are 
displayed in the figures below. Supplementary fig. 2 corresponds to the simulations of 
PPARγ – rosiglitazone (2PRG), fig. 3 PPARγ – MRL24 (2Q5P), fig. 4 PPARγ – decanoic 
acid (3U9Q), fig. 5 apo PPARγ structure and fig. 5 to parameters for the global embedding of 
all simulations together. Ticks on the stress (red) and correlation (blue) curves correspond to 
standard deviations at each 𝑟𝑐  value. Green curves represent the difference between mean 
correlation and mean stress. The grey dash-dotted vertical lines correspond to the optimal 𝑟𝑐. 
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Supplementary figure 2: Stress and correlation as a function of neighborhood radius using 
6000 conformations from the aMD trajectory of PPARγ – rosiglitazone structure. 
 
Supplementary figure 3: Stress and correlation as a function of neighborhood radius using 
6000 conformations from the aMD trajectory of PPARγ – MRL24 structure. 
 
Supplementary figure 4: Stress and correlation as a function of neighborhood radius using 
6000 conformations from the aMD trajectory of PPARγ – rosiglitazone. 
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Supplementary figure 5: Stress and correlation as a function of neighborhood radius using 
6000 conformations from the aMD trajectory of the 1PRG apo PPARγ structure. 
 
Supplementary figure 6: Stress and correlation as a function of neighborhood radius using 
24000 conformations from all aMD trajectories combined. 
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6. Unrolr pSPE embeddings of aMD simulations of PPARγ LBD complexes with 
MRL24, decanoic acid and apo PPARγ structure.  
 
Supplementary figure 7: Unrolr embedding for PPARγ – MRL24 structure. The 
conformations are binned with a bin size of 0.005 in both dimensions. Six densely-populated 
clusters with 25 aligned structures from each cluster are shown in the insets. Position of the 
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Supplementary figure 8: Unrolr embedding for PPARγ – decanoic acid structure. The 
conformations are binned with a bin size of 0.005 in both dimensions. Six densely-populated 
clusters with 25 aligned structures from each cluster are shown in the insets. Position of the 
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Supplementary figure 9: Unrolr embedding for the 1PRG apo PPARγ structure. The 
conformations are binned with a bin size of 0.005 in both dimensions. Six densely-populated 
clusters with 25 aligned structures from each cluster are shown in the insets. Position of the 
helix H1 in the aligned structures is labeled for clearance. 
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Izvleček 
 
PPARγ je jedrni receptor, ki ima osrednjo vlogo pri promociji rasti in diferenciacije 
adipocitov ter regulaciji nivoja glukoze in trigliceridov v krvi. Pri normalnih fizioloških 
pogojih je PPARγ tarča številnih post-translacijskih modifikacij, ki uravnavajo 
transkripcijsko aktivnost tega receptorja. Postranslacijska modifikacija PPARγ s strani od 
ciklina odvisne kinaze 5 (CDK5) vodi v supresijo specifičnih genov za povečevanje 
inzulinske občutljivosti, kar vodi k povečanemu tveganju za pojav sladkorne bolezni tipa 2 in 
srčno-žilnih obolenj. Predhodne študije so pokazale, da inhibicija fosforilacije PPARγ s strani 
CDK5, z vezavo liganda v aktivno mesto PPARγ povrne bazalni nivo transkripcije in 
ponovno poveča inzulinsko občutljivost posameznika. Mehanizem inhibicije na molekulski 
ravni ni popolnima razjasnjen. Čeprav se domneva, da se z vezavo liganda v aktivno mesto 
PPARγ vzpostavijo kritične interakcije med ligandom in proteinom, ki preprečijo molekulsko 
prepoznavanje CDK5, do sedaj še ni bilo nobenih eksperimentalnih izsledkov, ki bi 
potrjevale to hipotezo. V ta namen smo s simulacijami molekulske dinamike preučili vpliv 
različnih ligandov na strukturo in dinamiko interakcijske površine PPARγ za interakcijo s 
CDK5. S pomočjo metod klasične in pospešene molekulske dinamike smo podrobneje 
preučili komplekse PPARγ z ligandi treh aktivacijskih profilov, polnim agonistom 
rosiglitazone, delnim agonistom MRL24 in neagonistom dekanojsko kislino iz skupine 
srednjeverižnih maščobnih kislin. Naša opažanja so, da vezava liganda v aktivno mesto 
PPARγ dobro korelira z globalno stabilnostjo ligand-vezavne domene PPARγ. Nadaljnje 
raziskave bi bile potrebne za razločevanje razlik med ligandi z različnimi inhibitornimi in 
agonističnimi lastnostmi pri njihoven vplivu na dinamiko in konformacijske lastnosti PPARγ. 
 
Ključne besede: jedrni receptor, PPARγ, CDK5, fosforilacija, molekulska dinamika 
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Seznam uporabljenih kratic 
 
angl. - angleško 
PPAR – (angl. Peroxisome-proliferator activated receptor); jedrni hormonski receptor iz 
skupine PPAR 
LBD – ( angl. Ligand binding domain); ligand-vezavna domena  jedrnega receptorja 
RXRα – (angl. Retinoid x receptor alpha); retinoidni X receptor alfa 
DR – (angl. Direct repeat); odzivni element tipa DR, tj. zaporedje baznih parov z arhitekturo 
AGGTCA(X)nAGGTCA, kjer je X katerakoli dušikova baza in n zajema vrednosti od 1 do 5 
CDK5 – (angl. Cyclin-dependent kinase 5); od ciklina odvisna kinaza 5 
MD - Molekulska dinamika. 
CHARMM – (angl. Chemistry at Harvard molecular mechanics); ime programske opreme, 
ki se uporablja za poganjanje simulacij molekulske dinamike   
NAMD – (angl. Nanoscale Molecular Dynamics); programska oprema za poganjanje 
simulacij molekulske dinamike na vzporednih računalniških sistemih 
PDB – (angl. Protein Data Bank); podatkovna tridimenzionalnih struktur proteinov in 
nukleinskih kislin 
PSF – (angl. Protein Structure File); datoteka numeričnih vrednosti vseh molekulskih 
parametrov obravnavanega sistema, ki jih uporablja programska oprema CHARMM za 
poganjanje simulacij 
PME – (angl. Particle-Mesh Ewald); računska metoda za obravnavanje elektrostatskih 
interakcij v molekulski dinamiki 
aMD – (angl. Accelerated Molecular Dynamics); pospešena molekulska dinamika 
pSPE – (angl. Pivot-based Stochastic Proximity Embedding); nelinearna metoda za 
zmanjšanje razsešnosti nabora večdimenzionalnih podatkov 
RMSD – (angl. Root-mean-square deviation); parameter strukturnega prileganja 
tridimenzionalnih modelov dveh molekul 
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1. Uvod 
 
 Receptor PPARγ (angl. Peroxisome proliferator-activated receptor gamma) spada v 
družino jedrnih receptorjev. V človeškem genomu je bilo do sedaj odkritih 48 zapisov za 
jedrne receptorje, ki imajo osrednjo vlogo pri celični diferenciaciji, proliferaciji, apoptozi in 
regulaciji celične homeostaze [1]. Ker so vpleteni v številne fiziološke in patološke procese v 
organizmu, so izjemno pomembne tarče za razvoj zdravilnih učinkovin. 
 
1.1. Struktura in funkcija jedrnih receptorjev 
 
 V splošnem so jedrni receptorji sestavljeni iz šestih domen [2]. Najbolj ohranjena 
DNA-vezavna domena ali C-domena vsebuje dva motiva cinkovih prstov, ki se vežeta na 
dele DNA sekvence ustreznega zaporedja, imenovane odzivne elemente. Poleg tega vsebuje 
tudi dimerizacijsko površino za receptorje, ki tvorijo dimere. Ligand-vezavna domena ali E-
domena (angl. Ligand-binding domain – LBD), ki je druga najbolj ohranjena med jedrnimi 
receptorji in pogosto tudi največja domena, vsebuje prepoznavno mesto za vezavo liganda ter 
površinske motive za dimerizacijo in interakcijo s transkripcijskimi faktorji – korepresorji ali 
koaktivatorji transkripcije tarčnih genov jedrnega receptorja. Ostale tri domene, N-terminalna 
ali A/B domena, C-domena in F-domena se med posameznimi receptorji zelo razlikujejo tako 
po sekvenci kot po strukturi, funkeije nekaterih pa še niso povsem razjasnjene [2, 3]. 
 
1.2. Struktura E-domene in funkcija receptorja PPARγ 
 
 PPARγ je del družine receptorjev PPAR, v katero sodita še receptorja PPARα in 
PPAR β/δ. Vsi receptorji iz te družine so regulatorji metabolizma glukoze in lipidov [4]. 
Glavna funkcija PPARγ je regulacija diferenciacije adipocitov ter aktivnosti encimov 
lipogeneze v adipocitih. PPARγ obstaja v dveh izoformah, PPARγ1 in PPARγ2, ki se 
razlikujeta v dolžini N-terminalne domene in tkivni specifičnosti njunega izražanja. V 
celičnem jedru PPARγ tvori heterodimer z jedrnim receptorjem retinoidni X receptor alfa 
(RXRα). Heterodimer se na DNA poveže preko odzivnega elementa tipa DR-1 (angl. direct 
repeat-1) [5]. Transkripcijo tarčnih genov heterodimernega kompleksa PPARγ-RXRα 
aktivirajo ligandi, ki se vežejo v aktivno mesto ligand-vezavne domene kateregakoli izmed 
heterodimernih partnerjev. 
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 Od liganda odvisne strukturne spremembe v ligand-vezavni domeni se odražajo v 
regulaciji transkripcije tarčnih genov. Struktura ligand-vezavne domene receptorja PPARγ 
ima na terciarnem nivoju obliko troslojnega sendviča iz treh plasti α-vijačnice in ene 
antiparalelne β ploskve [6]. Pri transaktivaciji PPARγ imata ključno vlogo aktivno mesto in 
vijačnica H12, katere konformacija je odvisna od aktivacijskega profila liganda (agonist, 
delni agonist neagonist ali antagonist), vezanega v aktivno mesto. Konformacija H12 
modulira afiniteto PPARγ do vezave transkrpcijskih faktorjev (koaktivatorjev ali 
korepresorjev) in s tem vpliva na stopnjo transkripcije tarčnih genov kompleksa PPARγ-
RXRα [6]. 
 
1.3. Vpliv fosforilacije Ser245 na transkripcijo tarčnih genov PPARγ 
 
 PPARγ je pri normalnih fizioloških pogojev eden osrednjih regulatorjev izražanja 
genov za kontrolo lipogeneze in inzulinskega signaliziranja [7]. Choi et al. [8] so pokazali, da 
je post-translacijska fosforilacija PPARγ na Ser245 povezana s pojavom inzulinske rezistence 
– enega glavnih simptomov prekomerne debelosti in ključnih dejavnikov razvoja sladkorne 
bolezni tipa 2. Pokazali so, da inflamatorni procesi v maščobnem tkivu posameznikov, 
obremenjenih z debelostjo, vodijo do povečane stopnje fosforilacije Ser245 s strani od ciklina 
odvisne kinaze 5 (CDK5), katere posledica je podregulacija izražanja tarčnih genov PPARγ 
za adiponektin in adipsin – citokina, ki povečujeta inzulinsko občutljivost posameznika. Prav 
tako so ugotovili, da imajo določeni ligandi PPARγ, ki so bodisi agonisti ali delni agonisti, 
sposobnost preprečitve interakcije PPARγ s kinazo CDK5. Zaradi teh razlogov je bila 
uporaba inhibitorjev fosforilacije Ser245 s strani CDK5 predlagana kot ena od možnosti pri 
iskanju strategije za razvoj učinkovin za zdravljenje sladkorne bolezni [8]. 
 Natančen potek inhibicije fosforilacije Ser245 z molekularnega vidika kljub številnim 
mehanističnim študijam še zdaleč ni povsem razjasnjen [9, 10, 11]. Nerazrešene kristalne 
strukture CDK5, kompleksa PPARγ-CDK5/p25 ter velika podobnost tridimenzionalnih 
struktur ligand-vezavne domene PPARγ, kompeksirane z različnimi ligandi, so dejstva, ki 
otežujejo iskanje inhibitorjev fosforilacije PPARγ, vendar pa namigujejo k temu, da je 
inhibicija morebiti povezana z dinamiko strukture ligand-vezavne domene PPARγ. 
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2. Cilji magistrskega dela 
 
 Glavni cilj magistrskega dela je primerjati vpliv vezave različnih ligandov na 
strukturno dinamiko in konformacijo ligand-vezavne domene PPARγ. Dodatni cilj je 
korelirati vpliv ligandov z njihovo eksperimentalno določeno inhibitorno aktivnostjo proti 
fosforilaciji s strani CDK5. Motivacija za pristop k preučevanju omenjenega problema izvira 
iz hipotez, ki so jih postavile raziskovalne skupine (Mottin et al. [9], Ribeiro Filho et al. [10], 
and Montanari et al. [11]), ki so se s tem problemom predhodno ukvarjale, in sicer: 
- da je primarno mesto interakcije med PPARγ in CDK5 zanka H2-H2’, pri čemer sta za 
pravilno orientacijo in stabilizacijo proteinov pomembni še distalni regiji β-plast in 
zanka H2-H3’ na PPARγ 
- da je inhibicija fosforilacije na Ser245 posledica stabilizacije primarnih in distalnih 
regij z vzpostavitvijo verige hidrofobnih interakcij ob vezavi inhibitorja v vezavno 
mesto, pri čemer imata ključno vlogo aminokislini I341 in M348 
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3. Metode 
 
3.1. Simulacija molekulske dinamike 
 
 Simulacija molekulske dinamike (MD) je pomembno orodje pri raziskovanju 
strukturnih in dinamičnih lastnosti molekulskih sistemov [12]. V svojem bistvu simulacija 
vključuje postavitev začetne konfiguracije sistema – tj. začetnih koordinat in hitrosti vseh 
delcev ter uporabo Newtonovih enačb gibanja za izračun vseh nadaljnjih konfiguracij v 
odvisnosti od časa.  
 Za raziskovalne namene tega magistrskega dela sta bila uporabljena računalniška 
programa za izvajanje MD simulacij CHARMM [13] in NAMD [14], ki sta bila razvita 
izključno za preučevanje dinamičnih lastnosti bioloških makromolekularnih sistemov. 
 
3.2. Izgradnja simulacijskega modela 
 
 Prvi korak pri postavitvi biomolekularnega modela za simulacijo zahteva določitev 
tridimenzionalne kristalne strukture sistema, ki ga želimo preučevati. Za namen tega projekta 
smo iz spletne podatkovne baze proteinskih struktur PDB (angl. Protein Data Bank) potegnili 
pet rentgenskih kristalnih struktur ligand-vezavne domene PPARγ v obliki datotek s 
formatom pdb. Dve izmed njih sta bili strukturi apo proteina (PDB ID: 1PRG [15]), (PDB ID: 
3B3K [16]), ostali tri pa strukture kompleksa PPARγ z ligandom (PDB ID: 2PRG [15]), 
(PDB ID 2Q5P [17]) in (PDB ID: 3U9Q [18]). Iz vsake pdb datoteke so bile izbrisane 
koordinate vseh molekul razen enega monomera ligand-vezavne domene in molekule 
liganda. Simulacije so bile tako izvedene le na monomeru ligand-vezavne domene PPARγ. 
Koordinate aminokislin manjkajoče verige H2-H3’ v strukturah 2Q5P (K261 – S274) in 
3U9Q (K263 – S274) so bile določene s programom PyMOL [19], preko superpozicije vsake 
strukture s strukturo 2PRG. Koordinate vodikovih atomov so bile določene s programom 
CHARMM, protonacijska stanja histidinov pa s spletno aplikacijo propka [20] in vizualnim 
pregledom struktur s programom PyMOL [19]. 
 Določitvi vseh koordinat je sledila pretvorba prvotnih pdb datotek v datoteke formata 
crd, ki so neposredno berljive s programom CHARMM in zapis proteinske strukturne 
datoteke (angl. Proten Structure File, PSF) – datoteke, ki vsebuje informacije o topologiji 
molekule, vrstah atomov in pripadajočih delnih nabojih. Tako pretvorba formata pdb v crd 
kot zapis PSF datoteke sta bila izvedena s programom Leto [21]. 
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 Vse postavljene strukture so bile energijsko minimizirane s 700 koraki metode 
najstrmejšega spusta, pri čemer je bila fleksibilnost glavne in stranskih verig proteinskih 
struktur omejena s harmonskimi potenciali. Med minimizacijo sta bili uporabljeni 
poenostavitveni shemi “switch cutoff” v območju med 8.0 Å in 12.0 Å za izračun van der 
Waalsovih interakcij ter “shift cutoff” pri radiju 12.0 Å za izračun elektrostatskih interakcij. 
 Energijski minimizaciji je sledila solvatacija struktur z molekulami vode modela 
TIP3P ter dodatek enakih množin protiionov Na+ in Cl-. V solvatiranem modelu je bila za 
izračun elektrostatskih interakcij uporabljena metoda PME [22] (angl. Particle Mesh Ewald 
summation method). 
 
3.3. Simulacije MD ma modelu ligand-vezavne domene PPARγ 
 
 Energijsko minimizirane in solvatirane strukture so bile prenesene na HPC sisteme 
računalniških centrov Mesocentre v Strasbourgu in CINES v Monepellieru, kjer se je za 
vsako od petih proteinskih struktur s programom NAMD izvedlo 100 ns dolgo MD 
simulacijo v ansamblu NVE pri temperaturi 293.15 K. Pri simulaciji je bil za izračun časovne 
odvisnosti konfiguracij sistema uporabljen Verletov integracijski algoritem z dolžino koraka 
2 fs. Obravnava van der Waalsovih interakcij je bila poenostavljena s “switch cutoff” shemo 
med radijema 8.0 Å in 12.0 Å. Za elektrostatske interakcije se je še naprej uporabljala metoda 
PME. Za vsako proteinsko strukturo je bilo posnetih pet neodvisnih simulacij. 
 
3.4. Simulacije pospešene molekulske dinamike 
 
Pri štirih od petih struktur ligand-vezavne domene PPARγ (1PRG, 2PRG, 2Q5P in 3U9Q) je 
bila izvedena dodatna simulacija z metodo pospešene molekulske dinamike [23] (angl. 
accelerated molecular dynamics, aMD). To je metoda, ki omogoča obsežnejše vzorčenje 
konfiguracijskega prostora od klasične MD simulacije brez predhodnega poznavanja 
reakcijskih koordinat na energijski ploskvi sistema. Odvisna je le od dveh parametrov (α in 
Ethreshold), s katerima modificiramo energijsko ploskev. Za vse štiri strukture so bile posnete 
tri neodvisne aMD simulacije dolžine 100 ns v NPT ansamblu z nastavljeno temepraturo 
293.15 K in tlakom 1.01325 bar. Nevezne interakcije so bile obravnavane na enak način kot 
pri klasičnih MD simulacijah. 
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3.5. Analiza trajektorij, dobljenih iz aMD simulacij z metodo pSPE 
 
Za vpogled v obseg vzorčenja konfiguracijskega prostora in kvalitativno primerjavo med 
različnimi kompleksi ligand-vezavne domene PPARγ smo trajektorije vseh aMD simulacij 
analizirali z metodo za zmanjšanje dimenzij pSPE [24] (angl. pivot-based Stochastic 
Proximity Embedding). V naši analizi je bila uporabljena aplikacija Unrolr [25], Pythonova 
knjižnica, ki z implementacijo pSPE na heterogenih računalniških platformah omogoča hitro 
in enostavno procesiranje MD trajektorij. Za analizo z aplikacijo Unrolr so bile uporabljene 
tri neodvisne aMD simulacije vsakega kompleksa, iz katerih je bilo izvlečenih 600000 
posnetkov struktur. Vsak posnetek v simulaciji je bil “kodiran” s pseudo-dihedralnimi koti 
med Cα atomi glavne proteinske verige. Konformacijska “razdalja” med dvema izbranima 
posnetkoma je bila izračunana z uporabo dihedralne metrike [26]. Poleg posameznih struktur 
smo izračunali tudi “globalno” pSPE projekcijo vseh trajektorij združenih skupaj, ki je 
vsebovala 2400000 simulacijskih posnetkov. 
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4. Rezultati 
 
4.1. Rezultati klasičnih MD simulacij 
 
4.1.1. Časovna odvisnost RMSD 
 
 Iz petih neodvisnih trajektorij dolžine 100 ns smo izračunali časovno odvisnost 
količine RMSD (angl. Root-Mean-Square Deviation) za vsako od petih struktur ligand-
vezavne domene PPARγ. Iz Slike 1 je razvidno, da so vse simulacije tekom časa stabilne. 
Relativno nizke vrednosti RMSD v strukturah 2PRG in 2Q5P v primerjavi s strukturami 
1PRG, 3B3K in 3U9Q nakazujejo, da so strukture kompleksov PPARγ z ligandi, ki inhibirajo 
fosforilacijo (2PRG – ligand rosiglitazone in 2Q5P – ligand MRL24) v povprečju stabilnejše 
od ostalih struktur. 
 
 
Slika 1: Časovna odvisnost RMSD klasičnih MD simulacij različnih struktur ligand-vezavne 
domene PPARγ. RMSD vrednosti posamezne simulacije so izračunane iz razdalje med 
položaji atomov glavne verige po superpoziciji vseh struktur s strukturo prvega posnetka 
simulacije. 
 
4.1.2. RMSD profil glavne verige 
 
 Primerjava RMSD vrednosti v odvisnosti od posameznega aminokislinskega ostanka 
proteinske verige (Slika 2) je pokazala, da so v vseh petih  strukturah najbolj fleksibilni deli 
vijačnici H2, H2’ ter zanki H2-H2’ in H2’-H3. Po fleksibilnosti izstpa tudi vijačnica H12 v 
strukturi 3B3K, ki je struktura ligand-vezavne domene PPARγ v apo konformaciji. V 
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nasprotju z analizo časovne odvisnosti RMSD je iz profila RMSD po aminokislinah glavne 




Slika 2: Profil RMSD vrednosti po glavni verigi ligand-vezavne domene PPARγ. Posamezne 
krivulje predstavljajo srednje RMSD vrednosti atomov glavne verige C, Cα in N, povprečene 
po 5 neodvisnih simulacijah dolžine 100 ns. 
 
4.1.3. Analiza fleksibilnosti stranskih verig I341 in M348 
 
 Na podlagi hipoteze, ki so jo predlagali Ribeiro Filho et al. [10], tj. da vezava liganda 
z inhibitornim učinkom proti fosforilaciji Ser245 vodi to tvorbe verige hidrofobnih interakcij 
med aminokislinami I341, M348, I249 in L255, smo naredili analizo konformacijskega 
prostora stranskih verig slednjih aminokislin. S pomočjo Pythonove knjižnice MDAnalysis 
[27, 28] smo iz trajektorij klasičnih MD simulacij struktur PPARγ izvlekli vrednosti 
dihedralnih kotov 1 in 2 aminokislin I341, M348, I249 in L255. Slika 3 prikazuje 
porazdelitev dihedralnih kotov I341 v trajektorijah klasičnih simulacij. Medtem ko pri M348, 
I249 in L255 ni bilo opaženih očitnih razlik v porazdelitvi dihedralnih kotov med različnimi 
strukturami PPARγ, smo pri I341 opazili zoženje porazdelitve 1 in 2 pri obeh strukturah z 
inhibitorji fosforilacije (2PRG in 2Q5P). 
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Slika 3: Histogrami porazdelitve dihedralnih kotov 1 (oranžna) in 2 (modra) aminokisline 
I341 v klasičnih MD simulacijah. 
 
4.2. Rezultati simulacij pospešene molekulske dinamike 
 
4.2.1. Rezultati analize aMD trajektorij z metodo pSPE 
 
 Dvodimenzionalne pSPE projekcije trajektorij aMD simulacij, izračunane z aplikacijo 
Unrolr, so razkrile obseg vzorčenja konfiguracijskega prostora ligand-vezavne domene 
PPARγ. Slika 4.A prikazuje barvno shemo pSPE projekcij vseh trajektorij štirih strukur 
PPARγ. Slika 4.B ponazarja porazdelitveno-obarvano shemo globalne pSPE projekcije vseh 
aMD trajektorij. Modro obarvana območja predstavljajo pogosto vzorčene regije 
konfiguracijskega prostora – stanja z nativno strukturo in metastabilna stanja proteina, rdeče 
obarvana območja pa predstavljajo manj vzorčene konfiguracije, med katere spadajo 
prehodna stanja in stanja z razvito strukturo glavne verige. Zanimivo opažanje je, da strukturi 
PPARγ v kompleksu z inhibitorjem (2PRG in 2Q5P) vzorčita konfiguracijski prostor v 
manjšem obsegu in tudi v drugačnih regijah kot ostale strukture PPARγ (1PRG, 3B3K in 
3U9Q). To opažanje se dobro ujema z razlikami v RMSD vrednostih po času iz klasičnih MD 
simulacij. Vezava liganda, ki inhibira fosforilacijo očitno vodi k globalni stabilizaciji ligand-
vezavne domene PPARγ. 
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Slika 4A: Dvodimenzionalna pSPE projekcija trajektorij aMD simulacij. A,  global 
embedding of all aMD simulations. A, pSPE projekcija z barvno shemo za razločevanje 
med štirimi strukturami PPARγ . B, pSPE projekcija z barvno shemo na podlagi gostote 
konfiguracij. Območje je razdeljeno na razrede širine 0.005 v obeh dimenzijah. 
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5. Zaključek 
 
 V tem magistrskem delu sta bili uporabljeni tehniki simulacij klasične in pospešene 
molekulske dinamike pri preučevanju strukturne dinamike ligand-vezavne domene PPARγ 
kot apo strukture in v kompleksu z ligandi različnih agonističnih lastnosti in inhibitornih 
učinkovisti proti fosforilaciji. 
 Analiza RMSD vrednosti klasičnih MD simulacij po času je pokazala, da sta strukturi 
PPARγ v kompleksu z inhibitorjem fosforilacije bolj stabilni od ostalih struktur. Iz analize 
RMSD v odvisnosti od glavne proteinske verige je razvidno, da so v vseh strukturah najbolj 
fleksibilni deli proteina vijačnici H2 in H2’ ter zanki H2-H2’ in H2’-H3. Razlike v RMSD 
vrednostih med strukturami so bile povečini majhne in jih ni bilo mogoče pojasniti z vrsto 
liganda v vezavnem mestu (agonist/antagonist in/ali inhibitor fosforilacije). Zaradi tega 
razloga smo analizirali še fleksibilnost stranskih verig aminokislin I341, M348, I249 in L255 
v vezavnem mestu, ki naj bi sodelovale pri preprečitvi vezave CDK5 in inhibiciji fosforilacije 
v odvisnosti od liganda. Ugotovili smo, da je v strukturah kompleksov PPARγ z inhibitorjem 
fosforilacije (2PRG in 2Q5P) znatno zmanjšana fleksibilnost stranske verige I341 v 
primerjavi z ostalimi strukturami, kar podpira hipotezo, da za uspešno inhibicijo fosforilacije 
stoji stabilizacija I341, M348, I249 in L255 preko tvorbe hidrofobnih interakcij. 
 Analiza aMD simulacij z metodo pSPE je razkrila obseg vzorčenja struktur ligand-
vezavne domene PPARγ tekom simulacij. Projekcije pSPE na dvodimenzionalni ravnini so 
nazorno pokazale razlike v fleksibilnosti struktur PPARγ. Strukturi kompleksov PPARγ z 
inhibitorjem fosforilacije (2PRG in 2Q5P) vzorčita konfiguracijski prostor proteina v 
nekoliko ožjem obsegu in drugačnih regijah kot ostale strukture (1PRG, 3B3K in 3U9Q). To 
opažanje je v skladu z rezultati analize RMSD iz klasičnih MD simulacij in nakazuje, da 
vezava liganda, ki je inhibitor fosforilacije na Ser245, vodi v zoženje konfiguracijskega 
prostora in temu ustrezno zmanjšanje fleksibilnosti strukture ligand-vezavne domene PPARγ.  
 Za prihodnje študije na receptorju PPARγ predlagamo preučiti konformacijske in 
dinamične lastnosti PPARγ na kemijsko bolj raznolikem naboru ligandov, po možnosti 
eksperimentalno dokazanih inhibitorjev fosforilacije. Poleg tega bi bilo za večjo robustnost 
rezultatov potrebno izvesti dodatne neodvisne simulacije posameznega kompleksa z 
ligandom. In nenazadnje, zanimive rezultate bi lahko dala uporaba MD simulacij na 
računalniško sidranih proteinskih kompleksih med PPARγ in CDK5, preko katerih bi lahko 
neposredno primerjali vpliv različnih ligandov na stabilnost kompleksa PPARγ-CDK5 in 
sposobnost inhibicije fosforilacije na Ser245. 
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